Skip to main content
SpringerLink
Log in

Iris Melanoma

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology

Abstract

Iris melanoma is least frequent of all uveal melanomas. Because of anterior location, iris melanoma is diagnosed and treated when relatively small compared to tumors located in ciliary body and choroid. Melanoma located in the peripheral iris may represent anterior extension of a ciliary body tumor, and therefore it is of paramount importance to examine the ciliary body in cases of iris melanoma when all iris margins of the tumors are not visualized. Iris melanoma may be circumscribed or diffuse. Tapioca iris melanoma is a rare variant of diffuse iris melanoma. Slit-lamp examination, gonioscopy, and ultrasound biomicroscopy (UBM) allow staging of the tumor to guide the most appropriate treatment. Iris melanomas are managed by observation, incisional biopsy, excisional biopsy, or radiotherapy depending upon the size, extent, and visual potential. Iris melanomas tend to be less aggressive in comparison to melanomas in other uveal locations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rootman J, Gallagher RP. Color as a risk factor in iris melanoma. Am J Ophthalmol. 1984;98(5):558–61.

    Article  CAS  PubMed  Google Scholar 

  2. Khan S, Finger PT, Yu GP, et al. Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol. 2012;130(1):57–64.

    Article  PubMed  Google Scholar 

  3. Qian Y, Zakov ZN, Schoenfield L, et al. Iris melanoma arising in iris nevus in oculo(dermal) melanocytosis. Surv Ophthalmol. 2008;53(4):411–5.

    Article  PubMed  Google Scholar 

  4. Shields CL, Kaliki S, Hutchinson A, et al. Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide. Ophthalmology. 2013;120(4):766–72.

    Article  PubMed  Google Scholar 

  5. Medina CA, Biscotti CV, Singh N, et al. Diagnostic cytologic features of uveal melanoma. Ophthalmology. 2015;122(8):1580–4.

    Article  PubMed  Google Scholar 

  6. Scholz SL, Moller I, Reis H, et al. Frequent GNAQ, GNA11, and EIF1AX mutations in iris melanoma. Invest Ophthalmol Vis Sci. 2017;58(9):3464–70. https://doi.org/10.1167/iovs.17-21838.

    Article  CAS  PubMed  Google Scholar 

  7. de Lange MJ, Razzaq L, Versluis M, et al. Distribution of GNAQ and GNA11 mutation signatures in uveal melanoma points to a light dependent mutation mechanism. PLoS One. 2015;10(9):e0138002.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Krishna Y, Kalirai H, Thornton S, et al. Genetic findings in treatment-naive and proton-beam-radiated iris melanomas. Br J Ophthalmol. 2016;100(7):1012–6.

    Article  PubMed  Google Scholar 

  9. Harbour JW, Wilson D, Finger PT, et al. Gene expressing profiling of iris melanomas. Ophthalmology. 2013;120(1):213, e1–3.

    Article  PubMed  Google Scholar 

  10. Onken MD, Worley LA, Char DH, et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology. 2012;119(8):1596–603.

    Article  PubMed  Google Scholar 

  11. Zografos L, Uffer S. Tumeurs iriennes pigmentées. In: Zografos L, editor. Tumeursintraoculaires. Paris: Masson; 2002. p. 281–313.

    Google Scholar 

  12. Arentsen JJ, Green WR. Melanoma of the iris: report of 72 cases treated surgically. Ophthalmic Surg. 1975;6(2):23–37.

    CAS  PubMed  Google Scholar 

  13. Shields CL, Shields JA, Materin M, et al. Iris melanoma: risk factors for metastasis in 169 consecutive patients. Ophthalmology. 2001;108(1):172–8.

    Article  CAS  PubMed  Google Scholar 

  14. Shah PG, Shields CL, Shields JA, et al. Band keratopathy secondary to an iris melanoma. Cornea. 1991;10(1):67–9.

    Article  CAS  PubMed  Google Scholar 

  15. Brown D, Boniuk M, Font RL. Diffuse malignant melanoma of iris with metastases. Surv Ophthalmol. 1990;34(5):357–64.

    Article  CAS  PubMed  Google Scholar 

  16. Char DH, Crawford JB, Gonzales J, et al. Iris melanoma with increased intraocular pressure. Differentiation of focal solitary tumors from diffuse or multiple tumors. Arch Ophthalmol. 1989;107(4):548–51.

    Article  CAS  PubMed  Google Scholar 

  17. Demirci H, Shields CL, Shields JA, et al. Diffuse iris melanoma: a report of 25 cases. Ophthalmology. 2002;109(8):1553–60.

    Article  PubMed  Google Scholar 

  18. Ajamil Rodanes S, Garcia-Alvarez C, Saornil Alvarez MA, et al. Melanomalytic glaucoma secondary to iris melanoma. Arch Soc Esp Oftalmol. 2017;92(8):379–81.

    Article  CAS  PubMed  Google Scholar 

  19. Jakobiec FA, Silbert G. Are most iris “melanomas” really nevi? A clinicopathologic study of 189 lesions. Arch Ophthalmol. 1981;99(12):2117–32.

    Article  CAS  PubMed  Google Scholar 

  20. Harley MR, Rao R, Lally SE, et al. Malignant transformation of multifocal tapioca iris nevus in a child. J AAPOS. 2017;21(4):340–2.

    Article  PubMed  Google Scholar 

  21. Iwamoto T, Reese AB, Mund ML. Tapioca melanoma of the iris. 2. Electron microscopy of the melanoma cells compared with normal iris melanocytes. Am J Ophthalmol. 1972;74(5):851–61.

    Article  CAS  PubMed  Google Scholar 

  22. Reese AB, Mund ML, Iwamoto T. Tapioca melanoma of the iris. 1. Clinical and light microscopy studies. Am J Ophthalmol. 1972;74(5):840–50.

    Article  CAS  PubMed  Google Scholar 

  23. Haddad R, Konrad K, Stur M. Fine structure of tapioca melanoma of the iris. Doc Ophthalmol. 1985;61(2):157–65.

    Article  CAS  PubMed  Google Scholar 

  24. Zakka KA, Foos RY, Sulit H. Metastatic tapioca iris melanoma. Br J Ophthalmol. 1979;63(11):744–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Singh AD. Tumors of the uvea: benign melanocytic tumors. In: Singh AD, Damato BE, Pe’er J, et al., editors. In clinical ophthalmic oncology. Philadelphia: Saunders-Elsevier; 2007.

    Google Scholar 

  26. Taban M, Sears JE, Singh AD. Ciliary body naevus. Eye. 2007;21(12):1528–30.

    Article  CAS  PubMed  Google Scholar 

  27. Hale PN, Allen RA, Straatsma BR. Benign melanomas (nevi) of the choroid and ciliary body. Arch Ophthalmol. 1965;74(4):532–8.

    Article  CAS  PubMed  Google Scholar 

  28. LoRusso FJ, Boniuk M, Font RL. Melanocytoma (magnocellular nevus) of the ciliary body: report of 10 cases and review of the literature. Ophthalmology. 2000;107(4):795–800.

    Article  CAS  PubMed  Google Scholar 

  29. Frangieh GT, el Baba F, Traboulsi EI, et al. Melanocytoma of the ciliary body: presentation of four cases and review of nineteen reports. Surv Ophthalmol. 1985;29(5):328–34.

    Article  CAS  PubMed  Google Scholar 

  30. Damato EM, Damato B, Sibbring JS, et al. Ciliary body melanoma with partial deletion of chromosome 3 detected with multiplex ligation-dependent probe amplification. Graefes Arch Clin Exp Ophthalmol. 2008;246(11):1637–40.

    Article  CAS  PubMed  Google Scholar 

  31. Vasquez LM, Pavlin CJ, McGowan H, et al. Ring melanoma of the ciliary body: clinical and ultrasound biomicroscopic characteristics. Can J Ophthalmol. 2008;43(2):229–33.

    Article  PubMed  Google Scholar 

  32. Demirci H, Shields CL, Shields JA, et al. Ring melanoma of the anterior chamber angle: a report of fourteen cases. Am J Ophthalmol. 2001;132(3):336–42.

    Article  CAS  PubMed  Google Scholar 

  33. Aziz HA, Modi YS, Plesec TP, et al. Amelanotic Irido-Ciliary ring melanoma: a clinicopathological correlation. Ocul Oncol Pathol. 2016;2(3):153–5.

    Article  PubMed  Google Scholar 

  34. Kathil P, Milman T, Finger PT. Characteristics of anterior uveal melanocytomas in 17 cases. Ophthalmology. 2011;118(9):1874–80.

    Article  PubMed  Google Scholar 

  35. Shields JA, Shields CL. Cysts of the iris pigment epithelium. What is new and interesting? The 2016 Jose Rizal International Medal Lecture. Asia Pac J Ophthalmol (Phila). 2017;6(1):64–9. https://doi.org/10.22608/APO.201613.

    Article  Google Scholar 

  36. Augsburger JJ, Affel LL, Benarosh DA. Ultrasound biomicroscopy of cystic lesions of the iris and ciliary body. Trans Am Ophthalmol Soc. 1996;94:259–71; discussion 71–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Fine N, Pavlin CJ. Primary cysts in the iridociliary sulcus: ultrasound biomicroscopic features of 210 cases. Can J Ophthalmol. 1999;34(6):325–9.

    CAS  PubMed  Google Scholar 

  38. Shields CL, Shields JA, Cook GR, et al. Differentiation of adenoma of the iris pigment epithelium from iris cyst and melanoma. Am J Ophthalmol. 1985;100(5):678–81.

    Article  CAS  PubMed  Google Scholar 

  39. Rao A, Gupta V, Bhadange Y, et al. Iris cysts: a review. Semin Ophthalmol. 2011;26(1):11–22.

    Article  PubMed  Google Scholar 

  40. Lois N, Shields CL, Shields JA, et al. Primary cysts of the iris pigment epithelium. Clinical features and natural course in 234 patients. Ophthalmology. 1998;105(10):1879–85.

    Article  CAS  PubMed  Google Scholar 

  41. Denny MR, Seider MI. Surgical cystotomy of a large iris pigment epithelial cyst with microinstrumentation. Ocul Oncol Pathol. 2018;5:119–21.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Collins ME, Hariprasad SM. Images in clinical medicine. Free-floating iris cyst. N Engl J Med. 2010;362(18):1720.

    Article  CAS  PubMed  Google Scholar 

  43. Al-Kahtani E, Alkatan HM. Surgical treatment and histopathology of a symptomatic free-floating primary pigment epithelial iris cyst in the anterior vitreous. Middle East Afr J Ophthalmol. 2011;18(4):331–2.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Georgalas I, Petrou P, Papaconstantinou D, et al. Iris cysts: A comprehensive review on diagnosis and treatment. Surv Ophthalmol. 2018;63(3):347–64.

    Article  PubMed  Google Scholar 

  45. Hashida N, Ohguro N, Morimoto Y, et al. Ultrastructural appearance of iris flocculi associated with a thoracic aortic aneurysm and dissections. Br J Ophthalmol. 2009;93(10):1409–10.

    Article  CAS  PubMed  Google Scholar 

  46. Shields JA, Magrath GN, Shields C, et al. Dissecting aortic aneurysm 55 years after diagnosis of iris flocculi. Ocul Oncol Pathol. 2016;2(4):222–5.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Naumann G, Green WR. Spontaneous nonpigmented iris cysts. Arch Ophthalmol. 1967;78(4):496–500.

    Article  CAS  PubMed  Google Scholar 

  48. Lois N, Shields CL, Shields JA, et al. Primary iris stromal cysts. A report of 17 cases. Ophthalmology. 1998;105(7):1317–22.

    Article  CAS  PubMed  Google Scholar 

  49. Behrouzi Z, Khodadoust A. Epithelial iris cyst treatment with intracystic ethanol irrigation. Ophthalmology. 2003;110(8):1601–5.

    Article  PubMed  Google Scholar 

  50. Lockington D, Altaie R, Moore S, et al. Successful management of secondary iris cysts with viscoelastic-assisted endophotocoagulation. JAMA Ophthalmol. 2014;132(3):354–6.

    Article  PubMed  Google Scholar 

  51. Buckley RJ. Pathogenesis of the ICE syndrome. Br J Ophthalmol. 1994;78(8):595–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Bourne WM. Biology of the corneal endothelium in health and disease. Eye. 2003;17(8):912–8.

    Article  CAS  PubMed  Google Scholar 

  53. Wilson MC, Shields MB. A comparison of the clinical variations of the iridocorneal endothelial syndrome. Arch Ophthalmol. 1989;107(10):1465–8.

    Article  CAS  PubMed  Google Scholar 

  54. Le QH, Sun XH, Xu JJ. In-vivo confocal microscopy of iridocorneal endothelial syndrome. Int Ophthalmol. 2009;29(1):11–8.

    Article  PubMed  Google Scholar 

  55. Chiou AG, Kaufman SC, Beuerman RW, et al. Confocal microscopy in the iridocorneal endothelial syndrome. Br J Ophthalmol. 1999;83(6):697–702.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Levy SG, McCartney AC, Baghai MH, et al. Pathology of the iridocorneal-endothelial syndrome. The ICE-cell. Invest Ophthalmol Vis Sci. 1995;36(13):2592–601.

    CAS  PubMed  Google Scholar 

  57. Shields CL, Shields JA, Gross NE, et al. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104(8):1265–76.

    Article  CAS  PubMed  Google Scholar 

  58. Shields CL, Kaliki S, Crabtree GS, et al. Iris metastasis from systemic cancer in 104 patients: the 2014 Jerry A. Shields Lecture. Cornea. 2015;34(1):42–8.

    Article  PubMed  Google Scholar 

  59. Shields JA, Shields CL, Kiratli H, et al. Metastatic tumors to the iris in 40 patients. Am J Ophthalmol. 1995;119(4):422–30.

    Article  CAS  PubMed  Google Scholar 

  60. Augsburger JJ. Fine needle aspiration biopsy of suspected metastatic cancers to the posterior uvea. Trans Am Ophthalmol Soc. 1988;86:499–560.

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Kanthan GL, Jayamohan J, Yip D, et al. Management of metastatic carcinoma of the uveal tract: an evidence-based analysis. Clin Exp Ophthalmol. 2007;35(6):553–65.

    Article  PubMed  Google Scholar 

  62. Biscotti CV, Singh AD. Uveal metastases. Monogr Clin Cytol. 2012;21:17–30.

    Article  PubMed  Google Scholar 

  63. Shields JA, Shields CL, Lally SE, et al. Iris melanoma in a child simulating juvenile xanthogranuloma. Middle East Afr J Ophthalmol. 2018;25(2):115–7.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Janku L, Singh AD. Transillumination. In: Bergstrom C, Baker Hubbard C, Wells JR, et al., editors. Pocket guide to ocular oncology and pathology. Heidelberg: Springer; 2012.

    Google Scholar 

  65. Bianciotto C, Shields CL, Guzman JM, et al. Assessment of anterior segment tumors with ultrasound biomicroscopy versus anterior segment optical coherence tomography in 200 cases. Ophthalmology. 2011;118(7):1297–302.

    PubMed  Google Scholar 

  66. Skalet AH, Li Y, Lu CD, et al. Optical coherence tomography angiography characteristics of iris melanocytic tumors. Ophthalmology. 2017;124(2):197–204. https://doi.org/10.1016/j.ophtha.2016.10.003. Epub Nov 14.

    Article  PubMed  Google Scholar 

  67. Hau SC, Papastefanou V, Shah S, et al. Evaluation of iris and iridociliary body lesions with anterior segment optical coherence tomography versus ultrasound B-scan. Br J Ophthalmol. 2015;99(1):81–6. https://doi.org/10.1136/bjophthalmol-2014-305218. Epub 2014 Aug 4.

    Article  PubMed  Google Scholar 

  68. Maberly DA, Pavlin CJ, McGowan HD, et al. Ultrasound biomicroscopic imaging of the anterior aspect of peripheral choroidal melanomas. Am J Ophthalmol. 1997;123(4):506–14.

    Article  CAS  PubMed  Google Scholar 

  69. Marigo FA, Finger PT, McCormick SA, et al. Iris and ciliary body melanomas: ultrasound biomicroscopy with histopathologic correlation. Arch Ophthalmol. 2000;118(11):1515–21.

    Article  CAS  PubMed  Google Scholar 

  70. Singh AD, Pelayes DE, Brainard JA, et al. History, indications, techniques and limitations. Monogr Clin Cytol. 2012;21:1–9.

    PubMed  Google Scholar 

  71. Gokhale R, Medina CA, Biscotti CV, et al. Diagnostic fine-needle aspiration biopsy for iris melanoma. Asia Pac J Ophthalmol (Phila). 2015;4(2):89–91.

    Article  Google Scholar 

  72. Chronopoulos A, Kilic E, Joussen AM, et al. Small incision iris tumour biopsy using a cavernous sampling forceps. Br J Ophthalmol. 2014;98(11):1539–42. https://doi.org/10.1136/bjophthalmol-2014-305138. Epub 2014 Jun 25.

    Article  PubMed  Google Scholar 

  73. Finger PT, Milman T. Microincision, aspiration cutter-assisted multifocal iris biopsy for melanoma. Eur J Ophthalmol. 2017;27(1):62–6.

    Article  PubMed  Google Scholar 

  74. Naumann GO, Rummelt V. Block excision of tumors of the anterior uvea. Report on 68 consecutive patients. Ophthalmology. 1996;103(12):2017–27; discussion 27–8.

    Article  CAS  PubMed  Google Scholar 

  75. Harbour JW, Augsburger JJ, Eagle RC Jr. Initial management and follow-up of melanocytic iris tumors. Ophthalmology. 1995;102(12):1987–93.

    Article  CAS  PubMed  Google Scholar 

  76. Matthews BJ, Mudhar HS, Rennie IG. Trans-corneal fine cannula aspiration: Rycroft cannula aspiration technique for sampling iris tumours. Br J Ophthalmol. 2012;96(3):329–31.

    Article  PubMed  Google Scholar 

  77. Milman T, Petousis V, McCormick SA, et al. Anterior segment tumor aspiration cutter-assisted biopsy: experience with pathology. Am J Ophthalmol. 2011;152(5):776–83 e1.

    Article  PubMed  Google Scholar 

  78. Pe’er J, Frenkel S. Sector iridectomy of iris melanoma: a novel technique for excising the melanoma extraocularly. Br J Ophthalmol. 2011;95(10):1474–6.

    Article  PubMed  Google Scholar 

  79. Klauber S, Jensen PK, Prause JU, et al. Surgical treatment of iris and ciliary body melanoma: follow-up of a 25-year series of patients. Acta Ophthalmol. 2012;90(2):122–6.

    Article  PubMed  Google Scholar 

  80. Tsimpida M, Hungerford J, Arora A, et al. Plaque radiotherapy treatment with ruthenium-106 for iris malignant melanoma. Eye. 2011;25(12):1607–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Shields CL, Naseripour M, Shields JA, et al. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications. Am J Ophthalmol. 2003;135(5):648–56.

    Article  PubMed  Google Scholar 

  82. Reese AB, Cleasby GW. The treatment of iris melanoma. Am J Ophthalmol. 1959;47(5, Part 2):118–25.

    Article  CAS  PubMed  Google Scholar 

  83. Shields CL, Kancherla S, Patel J, et al. Clinical survey of 3680 iris tumors based on patient age at presentation. Ophthalmology. 2012;119(2):407–14.

    Article  PubMed  Google Scholar 

  84. Popovic M, Ahmed IIK, DiGiovanni J, et al. Radiotherapeutic and surgical management of iris melanoma: a review. Surv Ophthalmol. 2017;62(3):302–11.

    Article  PubMed  Google Scholar 

  85. Weisbrod DJ, Pavlin CJ, Xu W, et al. Long-term follow-up of 42 patients with small ciliary body tumors with ultrasound biomicroscopy. Am J Ophthalmol. 2010;149(4):616–22.

    Article  PubMed  Google Scholar 

  86. Damato B, Groenewald C. Uveal malignant melanoma: management options – resection techniques. In: Singh AD, Damato BE, Pe’er J, et al., editors. Clinical ophthalmic oncology. Philadelphia: Saunders Elsevier; 2007.

    Google Scholar 

  87. Rones B, Zimmerman LE. The prognosis of primary tumors of the iris treated by iridectomy. AMA Arch Ophthalmol. 1958;60(2):193–205.

    Article  CAS  PubMed  Google Scholar 

  88. Batioglu F, Gunalp I. Malignant melanomas of the iris. Jpn J Ophthalmol. 1998;42(4):281–5.

    Article  CAS  PubMed  Google Scholar 

  89. Cardine S, Labetoulle M, Kirsch O, et al. [Iris melanomas. A retrospective study of 11 patients treated by surgical excision]. J Fr Ophtalmol. 2003;26(1):31–7.

    Google Scholar 

  90. Alio JL, Fine IH. Minimizing incisions and maximizing outcomes in cataract surgery. New York: Springer; 2010.

    Book  Google Scholar 

  91. Rospond-Kubiak I, Damato B. The surgical approach to the management of anterior uveal melanomas. Eye (Lond). 2014;28(6):741–7.

    Article  CAS  Google Scholar 

  92. Allen JC. Incidence of photophobia in peripheral and sector iridectomy. Am J Ophthalmol. 1976;82(2):316–7.

    Article  CAS  PubMed  Google Scholar 

  93. Hood CT, Schoenfield LR, Torres V, et al. Iris melanoma. Ophthalmology. 2011;118(1):221–2.

    Article  PubMed  Google Scholar 

  94. Singh AD. Small incision guarded hydroaspiration of iris lesions. Br J Ophthalmol. 2017;101(11):1570–5.

    Article  PubMed  Google Scholar 

  95. Scheie HG, Yanoff M. Pseudomelanoma of the ciliary body. Report of a patient. Arch Ophthalmol. 1967;77(1):81–3.

    Article  CAS  PubMed  Google Scholar 

  96. El-Harazi SM, Kellaway J, Font RL. Melanocytoma of the ciliary body diagnosed by fine-needle aspiration biopsy. Diagn Cytopathol. 2000;22(6):394–7.

    Article  CAS  PubMed  Google Scholar 

  97. Rummelt V, Naumann GO, Folberg R, et al. Surgical management of melanocytoma of the ciliary body with extrascleral extension. Am J Ophthalmol. 1994;117(2):169–76.

    Article  CAS  PubMed  Google Scholar 

  98. Fabian ID, Thaung C, AlHarby L, et al. Late solitary extraocular recurrence from previously resected iris melanoma. Am J Ophthalmol. 2017;181:97–105. https://doi.org/10.1016/j.ajo.2017.06.025. Epub Jul 1.

    Article  PubMed  Google Scholar 

  99. Demirci H, Shields CL, Shields JA, et al. Ring melanoma of the ciliary body: report on twenty-three patients. Retina. 2002;22(6):698–706; quiz 852–3.

    Article  PubMed  Google Scholar 

  100. Finger PT. Plaque radiation therapy for malignant melanoma of the iris and ciliary body. Am J Ophthalmol. 2001;132(3):328–35.

    Article  CAS  PubMed  Google Scholar 

  101. Krema H, Simpson ER, Pavlin CJ, et al. Management of ciliary body melanoma with iodine-125 plaque brachytherapy. Can J Ophthalmol. 2009;44(4):395–400.

    Article  PubMed  Google Scholar 

  102. Fernandes BF, Krema H, Fulda E, et al. Management of iris melanomas with 125Iodine plaque radiotherapy. Am J Ophthalmol. 2010;149(1):70–6.

    Article  PubMed  Google Scholar 

  103. Razzaq L, de Keizer RJ. Ruthenium plaque radiation for iris and iridociliary melanomas: development of dry eyes? Br J Ophthalmol. 2010;94(11):1549–50.

    Article  CAS  PubMed  Google Scholar 

  104. Shields CL, Shah SU, Bianciotto CG, et al. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes. Ophthalmology. 2013;120(1):55–61.

    Article  PubMed  Google Scholar 

  105. Agraval U, Sobti M, Russell HC, et al. Use of Ruthenium-106 brachytherapy for iris melanoma: the Scottish experience. Br J Ophthalmol. 2018;102(1):74–8. https://doi.org/10.1136/bjophthalmol-2017-310278. Epub 2017 Jun 9.

    Article  PubMed  Google Scholar 

  106. Chaugule SS, Finger PT. Regression patterns of iris melanoma after Palladium-103 ((103)Pd) plaque brachytherapy. Ophthalmology. 2017;124(7):1023–30. https://doi.org/10.1016/j.ophtha.2017.02.015. Epub Apr 1.

    Article  PubMed  Google Scholar 

  107. Damato B, Kacperek A, Chopra M, et al. Proton beam radiotherapy of iris melanoma. Int J Radiat Oncol Biol Phys. 2005;63(1):109–15.

    Article  PubMed  Google Scholar 

  108. Rundle P, Singh AD, Rennie I. Proton beam therapy for iris melanoma: a review of 15 cases. Eye. 2007;21(1):79–82.

    Article  CAS  PubMed  Google Scholar 

  109. Dendale R, Lumbroso-Le Rouic L, Noel G, et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys. 2006;65(3):780–7.

    Article  PubMed  Google Scholar 

  110. Rahmi A, Mammar H, Thariat J, et al. Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases. Graefes Arch Clin Exp Ophthalmol. 2014;252(9):1515–21.

    Article  CAS  PubMed  Google Scholar 

  111. Konstantinidis L, Roberts D, Errington RD, et al. Whole anterior segment proton beam radiotherapy for diffuse iris melanoma. Br J Ophthalmol. 2013;97(4):471–4.

    Article  PubMed  Google Scholar 

  112. Singh AD, Dupps WJ Jr, Biscotti CV, et al. Limbal stem cell preservation during proton beam irradiation for diffuse iris melanoma. Cornea. 2017;36(1):119–22.

    Article  PubMed  Google Scholar 

  113. Leblanc A, Lumbroso-Le-Rouic L, Desjardins L, et al. Diffuse iris melanoma: conservative treatment with proton beam therapy after limbal stem cell preservation or enucleation?. Ocul Oncol Pathol. 2019. [epub ahead of print].

    Google Scholar 

  114. Tan AN, Hoevenaars JG, Webers CA, et al. Baerveldt implant for secondary glaucoma due to iris melanoma. Clin Ophthalmol. 2010;4:407–9.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Sharkawi E, Oleszczuk JD, Bergin C, et al. Baerveldt shunts in the treatment of glaucoma secondary to anterior uveal melanoma and proton beam radiotherapy. Br J Ophthalmol. 2012;96(8):1104–7.

    Article  PubMed  Google Scholar 

  116. Trichopoulos N, Damato B. Photodynamic therapy for recurrent hyphema after proton beam radiotherapy of iris melanoma. Graefes Arch Clin Exp Ophthalmol. 2007;245(10):1573–5.

    Article  CAS  PubMed  Google Scholar 

  117. Sandinha MT, Kacperek A, Errington RD, et al. Recurrence of iris melanoma after proton beam therapy. Br J Ophthalmol. 2014;98(4):484–7.

    Article  PubMed  Google Scholar 

  118. Riechardt AI, Klein JP, Cordini D, et al. Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1325–32. https://doi.org/10.1007/s00417-018-3929-5. Epub 2018 Feb 20.

    Article  PubMed  Google Scholar 

  119. Riechardt AI, Karle B, Cordini D, et al. Proton therapy of iris melanoma with 50 CGE: influence of target volume on clinical outcome. Strahlenther Onkol. 2017;193(11):943–50.

    Article  PubMed  Google Scholar 

  120. Aponte EP, Stern RM, Hayden BC, et al. Iridocorneal endothelial syndrome. Adv Ocul Care. 2010:31–2.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA

    Arun D. Singh

  2. Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK

    Bertil E. Damato

Authors
  1. Arun D. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bertil E. Damato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arun D. Singh .

Editor information

Editors and Affiliations

  1. University of Oxford, Oxford, UK

    Bertil E. Damato

  2. Cole Eye Institute Cleveland Clinic, Cleveland, OH, USA

    Arun D. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Singh, A.D., Damato, B.E. (2019). Iris Melanoma. In: Damato, B., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-17879-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17879-6_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17878-9

  • Online ISBN: 978-3-030-17879-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation